NCT05469100 - A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

August 7, 2019

Study Completion Date

August 7, 2019

Conditions

HealthyRenal Insufficiency

Interventions

DRUG

Selpercatinib

Administered orally

Trial Locations (6)

Riverside Clinical Research, Edgewater

Orlando Clinical Research Center, Orlando

Clinical Pharmacology of Miami, Miami

Orange County Research Center, Tustin

Anaheim Regional Center, Anaheim

Stanford Health Care, Valley Care Program, Pleasanton